Dolby Laboratories Announces Stock Repurchase Program
|
|
|
| Posted
:
Tue, 03 Nov 2009 21:22:20 GMT |
| Author
:
Dolby Laboratories, Inc.
|
| Category
:
Press Release |
| News Alerts by
Email ( click
here ) |
| Press Release
News |
Home
|
|
|
|
SAN FRANCISCO - (Business Wire) Dolby Laboratories, Inc. (NYSE:DLB) today announced that its Board of Directors has approved a stock repurchase program authorizing the Company to repurchase up to $250 million of its Class A Common Stock. The objective of the ongoing program is to offset dilution from the Company’s equity compensation programs. Stock repurchases under this program may be made through open market transactions, negotiated purchases, or otherwise, at times and in such amounts as Dolby considers appropriate. The timing of repurchases and the number of shares repurchased will depend on a variety of factors including price, regulatory requirements and other market conditions. Dolby may limit, suspend or terminate the stock repurchase program at any time without prior notice. Any shares repurchased under the program will be returned to the status of authorized but unissued shares of Class A Common Stock. Forward-Looking Statements Certain statements in this press release, including statements relating to Dolby’s intention to repurchase its Class A Common Stock in the future, are “forward-looking statements” that are subject to risks and uncertainties. These forward-looking statements are based on management’s current expectations, and as a result of certain risks and uncertainties, actual results may differ materially from those projected. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: risks associated with changing stock market conditions, Dolby’s ability to make appropriate, timely and beneficial decisions as to when, how, and whether to purchase shares under the stock repurchase program, alternative uses of Dolby’s capital and other risks detailed in Dolby’s Securities and Exchange Commission filings and reports, including the risks identified under the section captioned “Risk Factors” in its most recent Periodic Report on Form 10-Q or 10-K. Dolby disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise. About Dolby Laboratories Dolby Laboratories (NYSE:DLB) is the global leader in technologies that are essential elements in the best entertainment experiences. Founded in 1965 and best known for high-quality audio and surround sound, Dolby creates innovations that enrich entertainment at the movies, at home, or on the go. Visit www.dolby.com for more information. Dolby and the double-D symbol are registered trademarks of Dolby Laboratories. S09/22064 DLB-F Dolby Laboratories Investor Contact: Alex Hughes, 415-645-4572 investor@dolby.com Media Contact: David Yang, 415-645-5679 dyang@dolby.com
|

Copyright © 2008
Business Wire. All rights reserved.
|
|
|
|
|
Related
News
Inmarsat Completes Strategic Acquisition Focused on Government Services Business
LONDON, November 23 -- Inmarsat plc (LSE: ISAT),
the world's leading provider of global mobile satellite communications
services, today announces the acquisition of the business and assets of
Segovia, Inc. ("Segovia"). Bas...
GoldenSource Market Leadership Recognised in Financial News Tech21 List
LONDON, November 23 /PRNewswire/ -- GoldenSource has been recognised as a
leading innovator in financial markets technology by Financial News in its
4th annual Tech 21 list of innovators and market leaders for the 21st century.
GoldenSource wa...
Advanced ID Corp. Completes Repayment of La Jolla Cove Funding CALGARY, AB -- 11/23/09 --
Advanced ID Corporation (OTCBB: AIDO) a
leading developer of RFID solutions for supply chain applications, fleet
operations, animal tracking and tire management announces today that it has
fulfilled the terms of the Sept..
Research and Markets: 2009 Plimsoll Analysis - Abnormal Load Haulage - a Comprehensive Profile of 80 Companies Operating in the UK Market DUBLIN -
Research and Markets (
Aesthetic Plastic Surgery: The Next Generation Symposium Launches in NYC NEW YORK -
Aesthetic Plastic Surgery: The Next Generation Symposium will be held
from December 4-6 at the Waldorf Astoria, announces Z. Paul Lorenc, MD,
FACS, New York aesthetic plastic surgeon and Chairman of the APSSNY.
The CME-accredited three-day interactive conference, h
MedPro Safety Products Reports Recent Progress LEXINGTON, Ky. -
MedPro Safety Products, Inc. (OTCBB: MPSP), a pioneer in the development
and marketing of passive needlestick injury prevention technology, today
reported on the Company’s recent progress.
The recent highlights include:
Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain
NOVATO, Calif., Nov. 23 -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTP) today announced the presentation of clinical trial data on NGX426, the Company's orally administered, non-opioid, AMPA/kainate receptor antagonist...
|
|
|
|
|
|
|
|
|